Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
Institutional review boards (IRB) normally require of a morally defensible clinical trial that any trial participant will benefit from the inquiry, or at least not be exposed to a significant risk of having their prospects worsened by participating. Stage 1 HIV cure trials tend not to meet this requ...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2017
|
In: |
Journal of medical ethics
Year: 2017, Volume: 43, Issue: 2, Pages: 124-127 |
Online Access: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
LEADER | 00000caa a22000002 4500 | ||
---|---|---|---|
001 | 181615511X | ||
003 | DE-627 | ||
005 | 20230426115853.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220908s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/medethics-2015-103127 |2 doi | |
035 | |a (DE-627)181615511X | ||
035 | |a (DE-599)KXP181615511X | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 1 |2 ssgn | ||
100 | 1 | |a Kumar, Rahul |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Institutional review boards (IRB) normally require of a morally defensible clinical trial that any trial participant will benefit from the inquiry, or at least not be exposed to a significant risk of having their prospects worsened by participating. Stage 1 HIV cure trials tend not to meet this requirement. Does that show them to be morally indefensible? Utilitarian thinking about this question supports a negative answer. But one might reasonably expect a Kantian moral theory to support the conclusion that exposing trial participants to a significant risk of their prospects being worsened by their participation to be morally indefensible, on grounds that this would be a clear case of using a person as a mere means. In this paper, I argue, drawing on Kantian contractualist thinking, that requiring the risk/benefit ratio for participants be positive if a trial is to be morally defensible does not in fact gain any support from Kantian thinking about morality. | ||
773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d London : BMJ Publ., 1975 |g 43(2017), 2, Seite 124-127 |h Online-Ressource |w (DE-627)323607802 |w (DE-600)2026397-1 |w (DE-576)260773972 |x 1473-4257 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2017 |g number:2 |g pages:124-127 |
856 | |3 Volltext |u http://www.jstor.org/stable/44606078 |x JSTOR | ||
856 | |u https://jme.bmj.com/content/medethics/43/2/124.full.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via page says license)] | ||
856 | 4 | 0 | |u https://doi.org/10.1136/medethics-2015-103127 |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u http://jme.bmj.com/content/43/2/124.abstract |x Verlag |z kostenfrei |3 Volltext |
935 | |a mteo | ||
936 | u | w | |d 43 |j 2017 |e 2 |h 124-127 |
951 | |a AR | ||
ELC | |a 1 | ||
ITA | |a 1 |t 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 4185609051 | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 181615511X | ||
LOK | |0 005 20220908053705 | ||
LOK | |0 008 220908||||||||||||||||ger||||||| | ||
LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-03#CEE6DCA9EA6729DDB0FA4A9BD142F558427AF5D1 | ||
LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-Tue135 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/44606078 | ||
LOK | |0 935 |a ixzs |a ixrk |a zota | ||
OAS | |a 1 | ||
ORI | |a SA-MARC-ixtheoa001.raw |